Previous close | 23.28 |
Open | N/A |
Bid | 24.30 |
Ask | 27.00 |
Strike | 50.00 |
Expiry date | 2023-02-17 |
Day's range | 23.28 - 25.80 |
Contract range | N/A |
Volume | |
Open interest | 16 |
Beam Therapeutics Inc. ( NASDAQ:BEAM ) shareholders should be happy to see the share price up 16% in the last month...
The Nasdaq Composite has surged over 11% so far this month as growth stocks retake center stage. Shopify (NYSE: SHOP), the Vanguard Growth ETF (NYSEMKT: VUG), Nio (NYSE: NIO), Beam Therapeutics (NASDAQ: BEAM), and Roku (NASDAQ: ROKU) have that kind of potential. Here's what makes each company a great buy now, according to five Motley Fool contributors.
Three Motley Fool contributors were asked to identify great growth stocks down 20% or more to buy now. Here's why they chose Beam Therapeutics (NASDAQ: BEAM), Maravai LifeSciences (NASDAQ: MRVI), and Novavax (NASDAQ: NVAX). Keith Speights (Beam Therapeutics): Beam Therapeutics was flying high in the early part of 2021.